Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan Isenberg

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Analytical Cellular Pathology (Amsterdam)|May 25, 2011
Imatinib mesylate alters the expression of genes related to disease progression in an animal model of uveal melanomaBruno F Fernandes, Sebastian Di Cesare, Rubens Neto Belfort, et al.
Journal of Pathology Informatics|October 21, 2022
An integrated virtual pathology education platform developed using Microsoft Power Apps and Microsoft TeamsAjay Rajaram, Carel Olory, Valérie Leduc, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|April 18, 2016
Type 1 Boston keratoprosthesis: outcomes at two Canadian centresChristopher W Noel, Jordan Isenberg, Yakov Goldich, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Analytical Cellular Pathology (Amsterdam)|May 25, 2011
Imatinib mesylate alters the expression of genes related to disease progression in an animal model of uveal melanomaBruno F Fernandes, Sebastian Di Cesare, Rubens Neto Belfort, et al.
Journal of Pathology Informatics|October 21, 2022
An integrated virtual pathology education platform developed using Microsoft Power Apps and Microsoft TeamsAjay Rajaram, Carel Olory, Valérie Leduc, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|April 18, 2016
Type 1 Boston keratoprosthesis: outcomes at two Canadian centresChristopher W Noel, Jordan Isenberg, Yakov Goldich, et al.
Pageof 2